Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 1
2(33.3%)
6Total
N/A(4)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT01124903Not ApplicableCompleted

Human Hydration Status Monitoring

Role: collaborator

NCT03165175Not ApplicableCompleted

Mobile Application for Prescription Drug-Abuse Education (MAPDE)

Role: collaborator

NCT03080597Not ApplicableCompleted

PrEP for HBCUs (Study 2)

Role: collaborator

NCT03069768Phase 1Withdrawn

Stage Ib Trial of mSMART With Varenicline

Role: collaborator

NCT02635919Not ApplicableUnknown

Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence

Role: collaborator

NCT02895893Phase 1Completed

PrEP SMART Phase I Trial

Role: collaborator

NCT02072005Completed

Mobile App Based Personalized Solutions and Tools for Medication Adherence of Rx Pills

Role: collaborator

All 7 trials loaded